This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nantong University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations in Hemostasis: The Contributions of Pengxiang Yang
Introduction
Pengxiang Yang is a notable inventor based in Nantong, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of hemostatic agents. His innovative work aims to address critical medical challenges, particularly in managing hemorrhage.
Latest Patents
Yang holds a patent for a hemostatic agent specifically designed for jaw central hemangioma hemorrhage. The patent describes a preparation method and application of this agent, which involves the reaction of chitosan powder and organic weak acid in organic alcohol to create a chitosan weak acid salt. This hemostatic agent exhibits excellent fluidity and plasticity, allowing it to effectively reach the site of hemorrhage without causing tissue damage. Additionally, it has antibacterial properties that help prevent cross-infection, making it a safe and effective solution for treating massive hemorrhage in clinical settings.
Career Highlights
Pengxiang Yang is affiliated with Nantong University, where he continues to advance his research in biomedical engineering. His work has garnered attention for its practical applications in medical treatments, particularly in surgical and emergency care.
Collaborations
Yang has collaborated with esteemed colleagues such as Yongjun Wang and Luzhong Zhang. Their combined expertise has contributed to the successful development and application of innovative medical solutions.
Conclusion
Pengxiang Yang's contributions to the field of hemostatic agents represent a significant advancement in biomedical engineering. His innovative approaches not only enhance patient care but also pave the way for future research and development in medical treatments.